Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Amgen Inc. AMGN

Healthcare  —  Drug Manufacturers General
414.61 8.57 2.11% as of 25 Sep
Market cap
$219.1B
P/E
25.6×
S&P 500 Member Dividend Champion (10y) Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Amgen Inc. (AMGN) P/B ratio

As of 25 September 2026, Amgen Inc. (AMGN) trades at a P/B ratio of 19.2×. Over the past ten years it has ranged from 3.3× (November 2016) to 154× (May 2022); the current reading is higher than 66% of that period. That is above the Drug Manufacturers General industry median of 5.0× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 20.3× (14.60%)
FY2024 23.8× (6.72%)
FY2023 25.5× (33.60%)
FY2022 38.5× 100.90%
FY2021 19.1× 33.66%
FY2020 14.3× (5.03%)
FY2019 15.1× 46.47%
FY2018 10.3× 100.82%
FY2017 5.1× 35.83%
FY2016 3.8× (13.87%)

Quarterly

Period P/B ratio Change
Jun 2026 16.7× (19.08%)
Mar 2026 20.7× 1.65%
Dec 2025 20.3× 28.86%
Sep 2025 15.8× (21.95%)
42 more quarters

Against its own ten years

Low 3.3× High 154×
Ten-year median 14.2×
Current reading's percentile 66

P/B ratio against peers

Company P/B ratio
ABBV AbbVie Inc. compare n/m
PFE Pfizer Inc. compare 1.9×
NVO Novo Nordisk A/S compare 5.0×
AZN AstraZeneca PLC compare 5.1×
BMY Bristol Myers Squibb Company compare 5.8×
NVS Novartis AG compare 6.6×
MRK Merck & Co., Inc. compare 8.8×
GILD Gilead Sciences, Inc. compare 16.0×
AMGN Amgen Inc. 19.2×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on AMGN